The research, led by Yuhang Wu, Shi Gu, and colleagues at Zhejiang University, the University of Electronic Science and Technology of China, New York University, and the University of Pennsylvania, including network neuroscientist Dani S. Bassett, took a deliberately controlled approach. Rather than embedding their networks in physical space and imposing wiring-cost constraints, the team trained recurrent neural networks (RNNs) on batteries of cognitive tasks of the kind long used in systems neuroscience: working memory, perceptual decision-making, context-dependent categorization, and other tasks that probe the computational repertoire of prefrontal and parietal cortex. The question was simple but profound: if you strip away all spatial and metabolic pressure, does modularity still appear when a network must learn many demanding tasks at once?

The answer was a resounding yes. Networks trained under multitask learning paradigms developed significantly higher modularity than networks trained on a single task, and the effect grew stronger as the task load pushed against the network’s capacity. When the number of simultaneous tasks strained what the fixed pool of units could compute, the networks responded by reorganizing their internal connectivity into functionally segregated communities. This is a striking result because nothing in the training objective rewarded modularity directly. The networks were optimized only for task performance, yet the pressure of limited capacity and diverse demands was sufficient to carve the connectivity matrix into modules—much as the pressure of diverse cognitive demands may have shaped the brain’s own architecture.

The study went further by comparing different training regimes. Networks trained with incremental multitask learning—in which tasks were introduced sequentially and the network had to integrate each new demand into an already functioning system—developed the highest degree of modularity of all, while also maintaining superior performance across the full task set. This detail matters because it mirrors the developmental trajectory of biological brains, which do not acquire all cognitive abilities simultaneously but build them progressively over years of experience. The finding suggests that the order and pacing of task acquisition, not merely the total computational load, shapes the topology that emerges. Modularity, in this view, is not a static design feature but an adaptive response to the sequential introduction of complex problems.

Technically, the team quantified modularity using established network-science measures, including community-detection methods of the kind pioneered by Leicht and Newman for directed networks, applied to the learned weight matrices of the RNNs. They tracked how modular structure unfolded over the course of training, revealing that community boundaries sharpened as learning progressed and as additional tasks accumulated. They also examined the incremental addition of connections during learning, drawing an intriguing parallel to the lottery ticket hypothesis from deep learning research—the idea that sparse, trainable subnetworks exist within larger networks and are the components that effectively carry the computational load. In the task-trained RNNs, sparse modular substructures appeared to play an analogous role, suggesting a possible computational rationale for why both artificial and biological learning systems might favor segregated, sparsely interconnected architectures.

Perhaps the most consequential finding came when the researchers compared their task-induced networks against biological data. Using structural connectivity data from the Human Connectome Project, covering 84 cortical areas, they evaluated how closely the artificial networks matched the brain’s own organization. The task-trained networks exhibited structural properties that more closely resembled biological brain networks than models based solely on spatial constraints such as wiring-cost minimization. In other words, functional demand—the need to compute—appears to be a stronger organizing principle for brain-like topology than physical economy alone. This does not mean spatial constraints are irrelevant; the brain is certainly shaped by the geometry of the skull and the metabolic cost of axons. But the new results demonstrate that spatial models alone cannot fully explain the functional organization of brain networks, and that computational pressure fills a substantial part of that explanatory gap.

The work builds on a rich lineage of research at the intersection of machine learning and neuroscience. Previous studies had shown that RNNs trained on many cognitive tasks develop mixed selectivity and shared dynamical motifs that support flexible behavior, and that spatially embedded RNNs recapitulate numerous structural and functional findings from neuroscience. Other work demonstrated that brain-like functional specialization can emerge spontaneously in deep networks trained on naturalistic tasks. The new study adds a crucial piece: a controlled computational demonstration that modularity itself—arguably the signature feature of brain network organization—can be induced purely by the functional demands of multitask learning under capacity constraints. It thereby offers a causal, mechanistic account where earlier work offered correlations or spatial explanations.

The implications run in both directions. For neuroscience, the study provides a testable framework: if modularity is an adaptive response to cumulative cognitive demands, then developmental changes in brain network segregation should track the acquisition of complex abilities, a hypothesis consistent with prior findings that modular segregation of structural brain networks supports the development of executive function in youth. For artificial intelligence, the results hint at design principles for more adaptable machines. Modular deep learning has become a vibrant field precisely because modular systems can learn new skills without catastrophically forgetting old ones, and this study suggests that simply structuring the training curriculum—introducing tasks incrementally under realistic capacity limits—can coax modularity into existence without hand-engineered architectural constraints. That could inform how researchers build continual-learning systems, from robotics to large multimodal models, where flexibility and stability must coexist.

The study also speaks to a long-standing debate about the economy of brain network organization. The brain has often been described as a compromise between wiring cost and topological value, with small-world architecture emerging from that trade-off. The new findings suggest the ledger has more entries than previously appreciated: computational value, capacity limits, and the temporal sequence of learning demands all leave structural fingerprints. Modularity may be less a consequence of saving wire and more a consequence of solving problems—a functional adaptation that spatial economy then refines rather than creates. As the authors put it in their abstract, modularization emerges as an adaptive response to the sequential introduction of complex tasks, a framing that reframes the brain’s architecture as the product of a computational curriculum written by evolution and experience.

The team has released its code and processed connectivity data publicly via GitHub and Zenodo, allowing other researchers to reproduce the simulations and extend the approach to new task sets, architectures, and species comparisons. Cross-species network comparisons, representational similarity analyses, and generative models of the connectome are natural next steps, and the framework could eventually be applied to clinical questions, since many neuropsychiatric conditions involve disruptions of modular brain organization. For now, the study stands as a vivid example of a growing trend in modern science: artificial neural networks are no longer just engineering tools but instruments for asking why questions about the brain—and, increasingly, they are answering with structures that look strikingly familiar. When a machine learns the way a mind must, it begins, it seems, to build itself the way a brain is built.

Subject of Research: Emergence of task-driven modular network organization in recurrent neural networks and its alignment with human brain architecture

Article Title: Task-structured modularity emerges in artificial networks and aligns with brain architecture

Article References: Wu, Y., Deng, S., Du, K., Mattar, M. G., Wu, Y., Bassett, D. S., Tang, H., Pan, G., & Gu, S. (2026). Task-structured modularity emerges in artificial networks and aligns with brain architecture. Nature Machine Intelligence. https://doi.org/10.1038/s42256-026-01306-9

Image Credits: AI Generated

DOI: 10.1038/s42256-026-01306-9

Keywords: recurrent neural networks, multitask learning, modularity, brain networks, connectome, cognitive tasks, network neuroscience, Human Connectome Project, continual learning, wiring cost, lottery ticket hypothesis, Nature Machine Intelligence

Researchers set out to map the structural connectomes, the comprehensive wiring diagrams of neural fiber tracts, of patients with severe, treatment-refractory obsessive-compulsive disorder, and to compare how the conventional deep brain stimulation targets are embedded within each individual’s connectome. Using diffusion magnetic resonance imaging, the team reconstructed the white matter pathways that connect distant brain regions and analyzed how the stimulation sites commonly used in clinical practice relate to the broader network organization of each patient’s brain. The central question was deceptively simple: when two patients receive stimulation at the same anatomical coordinate, are they actually stimulating the same circuit?

The answer, according to the findings, is a resounding no. The study revealed substantial patient-specific differences in the structural connectivity profile of the target regions most frequently used for obsessive-compulsive disorder, including the anterior limb of the internal capsule, the ventral capsule and striatum, the nucleus accumbens, and the bed nucleus of the stria terminalis. While these targets occupy broadly similar positions across patients, the specific fiber bundles passing through and around them, and the cortical and subcortical regions they link, vary considerably from one individual to the next. A coordinate that engages a particular fronto-striatal loop in one patient may recruit a partially different set of tracts and connection patterns in another.

This variability has profound implications for a field that has traditionally relied on group-averaged atlases to guide electrode placement. Standard neurosurgical practice often positions electrodes according to population-level templates, on the assumption that a given target occupies a comparable network position in most patients. The new connectomic analysis challenges that assumption directly. If the structural context of a target differs substantially across patients, then identical electrode placements may produce heterogeneous network effects, potentially explaining some of the striking inconsistency in clinical outcomes that has plagued obsessive-compulsive disorder stimulation studies for two decades.

Obsessive-compulsive disorder affects roughly one to two percent of the global population, characterized by intrusive, distressing obsessions and repetitive compulsions that can consume hours of each day. For the majority of patients, cognitive behavioral therapy and serotonin reuptake inhibitors provide meaningful relief. But a stubborn minority, estimated at around ten percent, derive little benefit from any conventional treatment. It is this treatment-resistant group for whom deep brain stimulation has been developed, and for whom the stakes of targeting precision are highest. The procedure is invasive, expensive and not without risk, so improving the odds of a successful outcome carries real clinical weight.

The technical approach behind the study relied on diffusion-weighted imaging, which tracks the directional movement of water molecules along axonal bundles to infer the trajectories of white matter tracts. From these data, the researchers constructed individualized connectomes, assigning each stimulation target a connectivity fingerprint describing which brain regions it is structurally linked to and with what strength. By quantifying the overlap and divergence of these fingerprints across patients, the team could measure, for the first time in a systematic way, how much of the apparent uniformity of standard targets is an artifact of averaging, and how much genuine inter-individual variation persists even in a relatively homogeneous patient population.

The results showed that while certain broad network features are conserved, including strong connections between the ventral capsule and striatal targets and prefrontal cortical regions implicated in compulsive behavior, the fine-grained connectivity differs in ways that could be clinically consequential. Some patients exhibited connectivity profiles that aligned closely with the tracts most often associated with favorable stimulation responses in the published literature, such as pathways linking the ventral striatum with medial frontal and limbic regions. Others showed markedly different configurations, with key tracts displaced or attenuated relative to the group average. In such patients, an electrode placed at the conventional coordinate might miss the optimal tract entirely, or engage competing pathways with unknown effects.

These findings dovetail with a growing body of evidence that the therapeutic effect of deep brain stimulation depends less on the precise anatomic address of an electrode and more on the specific white matter tracts it modulates. Parallel work in Parkinson’s disease, dystonia and treatment-resistant depression has converged on the idea that connectivity-informed targeting outperforms anatomy-informed targeting, and that tractographic models derived from patient-specific imaging can predict clinical outcomes better than distance from a group-defined sweet spot. The present study extends this connectomic framework to obsessive-compulsive disorder, providing quantitative evidence that the field’s conventional targets are not network-equivalent across patients.

The clinical implications are straightforward, even if their implementation will take time. The findings argue for incorporating individual diffusion imaging and connectomic analysis into the pre-surgical planning of deep brain stimulation for obsessive-compulsive disorder, rather than relying exclusively on atlas coordinates. They also suggest a framework for rational electrode adjustment, in which a patient’s poor response to stimulation could be reinterpreted as a wiring mismatch rather than a failure of the therapy itself, prompting tractography-guided revision. As imaging pipelines become faster and more automated, the marginal cost of patient-specific connectomic planning continues to fall, bringing such approaches closer to routine practice.

Important caveats remain. The study examined structural connectivity, the brain’s physical wiring, and did not directly measure function or clinical response, so the link between connectomic variability and therapeutic outcome, while strongly suggested, awaits direct validation in longitudinal cohorts. Diffusion imaging itself carries known limitations in resolving crossing fibers and distinguishing fiber populations. Nonetheless, the central message stands with unusual clarity: the brain targets that surgeons stimulate are not interchangeable points on a map, but individualized nodes in each patient’s unique neural network. For a disorder as heterogeneous and disabling as obsessive-compulsive disorder, that individuality may prove to be the key that finally unlocks consistent benefit from one of medicine’s most remarkable interventions.

Subject of Research: Patient-specific structural connectomic variability of deep brain stimulation targets in treatment-resistant obsessive-compulsive disorder

Article Title: Patient-specific structural connectomic differences of deep brain stimulation targets in treatment-resistant obsessive-compulsive disorder patients

Article References: Patient-specific structural connectomic differences of deep brain stimulation targets in treatment-resistant obsessive-compulsive disorder patients. (n.d.). https://doi.org/10.1038/s41398-026-04441-4

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04441-4

Keywords: deep brain stimulation, obsessive-compulsive disorder, connectomics, treatment-resistant OCD, diffusion MRI, white matter tracts, ventral capsule, nucleus accumbens, neurosurgery, translational psychiatry, brain networks, Patient-specific

The research, which the authors describe as a framework of state-primed modulation, argues that the efficacy of a TMS pulse is not fixed. Instead, it depends dynamically on the ongoing activity of the neural circuits being targeted. The brain is never at rest in a uniform sense; cortical networks oscillate continuously between states of high excitability and relative quiescence, shaped by sleep, alertness, mood, recent cognitive activity and intrinsic rhythmic fluctuations. A pulse delivered when a circuit is primed for plasticity may trigger far stronger and longer-lasting changes than an identical pulse delivered seconds earlier or later, when the same circuit is in a less receptive configuration.

This idea builds on a well-established principle from neuroscience known as spike-timing-dependent plasticity. In laboratory studies of synapses, the strength of connections between neurons changes depending on the precise timing of pre- and post-synaptic firing: firing that coincides in a specific temporal window tends to strengthen connections, whereas mistimed activity can weaken them or leave them unchanged. TMS, despite its coarse spatial resolution, acts on the same biological substrate. If the magnetic pulse arrives when the target network is already oscillating in a favorable phase, the induced currents can amplify the ongoing pattern, driving activity-dependent plasticity more effectively. The new work extends this reasoning from single synapses to the level of large-scale brain networks involved in mood regulation and cognition.

Technically, the framework combines standard TMS hardware with real-time monitoring of brain state. Electroencephalography, which measures the brain’s electrical rhythms through the scalp, provides a continuous readout of cortical oscillations. By analyzing these signals moment by moment, a closed-loop system can identify windows of heightened excitability in the target region—such as the dorsolateral prefrontal cortex, a hub commonly stimulated in depression—and trigger stimulation precisely within those windows. The study describes a sequential enhancement strategy, in which initial stimulation sessions are used to characterize and nudge a patient’s brain state into more favorable configurations, and subsequent pulses are then delivered at optimal moments to consolidate and amplify the therapeutic effect.

The implications for psychiatric treatment are substantial. Depression has increasingly been reframed as a disorder of brain network dynamics rather than simply a chemical imbalance. Large-scale networks such as the default mode network, which is active during introspection and rumination, and the frontoparietal executive network, which supports cognitive control, often show disrupted coordination in depressed patients. Effective treatment appears to require a rebalancing of these systems. If stimulation can be timed to coincide with the phases of network activity most conducive to rewiring, clinicians may be able to achieve in fewer sessions what currently takes many, and to help patients who have historically failed to respond.

What makes the approach particularly appealing is its practical accessibility. Unlike imaging-guided neuromodulation approaches that depend on expensive real-time functional MRI, EEG-based closed-loop TMS uses equipment that is already present in many clinics. The core innovation is not new hardware but a new treatment logic: rather than treating every pulse as identical, the system adapts each pulse to the patient’s fluctuating neural state. This turns the inherent variability of brain activity from a nuisance into an opportunity, allowing the same standard technology to deliver more consistent and potentially more powerful therapeutic outcomes.

The sequential element of the strategy is equally important. The authors emphasize that state-primed modulation is not a single intervention but a protocol that unfolds over time. Early sessions both gather information about an individual’s characteristic brain rhythms and begin shifting the target circuitry toward a more plastic, receptive state. Later sessions then exploit that heightened receptivity, delivering stimulation when the conditions for lasting synaptic change are most favorable. In this sense the protocol mirrors principles used in physical rehabilitation and learning, where repeated, well-timed practice drives progressively deeper adaptation. Applied to the brain, the same logic may explain why cumulative stimulation schedules are often more effective than isolated sessions—and why adding precise timing could amplify those gains.

Cautious optimism is warranted. Closed-loop brain stimulation is a rapidly moving field, and previous promising concepts have faced challenges when translated from the laboratory to heterogeneous clinical populations. Individual differences in skull anatomy, coil positioning, EEG signal quality and underlying pathology all introduce variability that adaptive algorithms must handle robustly. Large, well-controlled trials across diagnostic groups will be needed to confirm that the benefits observed in this framework generalize beyond controlled research settings. Regulatory and practical questions—how to standardize state detection, how to define responsiveness thresholds, and how to train clinicians in adaptive protocols—remain open.

Nevertheless, the study marks an important conceptual shift in neuropsychiatry. For decades, brain stimulation protocols have been designed around fixed parameters: a target location, a stimulation intensity, a frequency, and a schedule. The state-primed modulation framework replaces that static picture with a dynamic one, in which treatment adapts continuously to the living brain it seeks to heal. If subsequent trials validate the approach, the future of TMS may look less like a set appointment with a coil and more like a conversation with the brain—one in which the device listens to cortical rhythms, waits for the right moment, and then speaks at precisely the time the brain is ready to hear. For the millions of patients with psychiatric disorders who have not been helped by existing treatments, that conversation cannot come soon enough.

Subject of Research: Sequential enhancement of transcranial magnetic stimulation efficacy through brain-state-primed modulation for psychiatric disorders

Article Title: State-Primed modulation: sequential enhancement of transcranial magnetic stimulation efficacy for psychiatric disorders

Article References: Xu, W., Tang, E., Li, X., Ye, S., & Zhou, D. (2026). State-Primed modulation: sequential enhancement of transcranial magnetic stimulation efficacy for psychiatric disorders. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04471-y

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04471-y

Keywords: transcranial magnetic stimulation, TMS, brain state, neuromodulation, psychiatric disorders, depression, EEG, closed-loop stimulation, neural plasticity, prefrontal cortex, brain networks, Translational Psychiatry

The biological definition of Alzheimer’s disease rests on two proteinopathies: extracellular amyloid-beta plaques and intracellular tau neurofibrillary tangles. Under modern biomarker-based criteria, a positive amyloid test combined with evidence of tau pathology is sufficient to establish the disease biologically, regardless of which symptoms a patient shows. Yet the two hallmark proteins do not strike the brain uniformly. In typical Alzheimer’s disease, tau accumulates early in the medial temporal lobe, and memory fails first. In atypical forms, the same molecular process unfolds with a strikingly different geographic signature, sparing the hippocampus and instead devastating posterior cortical regions, left-hemisphere language networks, frontal-executive circuits, or motor and praxis-related areas.

The review catalogs the principal atypical presentations. Posterior cortical atrophy begins with visual disturbances, including difficulty reading, judging spatial relationships, and recognizing objects, and is frequently misdiagnosed as ophthalmological disease for years. Logopenic variant primary progressive aphasia erodes word-finding and sentence repetition, often sending patients to speech-language pathologists before any dementia specialist is involved. Behavioral and dysexecutive Alzheimer’s disease mimics frontotemporal dementia, with disinhibition, apathy, impaired planning, or poor judgment dominating the early course. Corticobasal syndrome, classically associated with the tauopathy corticobasal degeneration, can in a subset of cases prove at autopsy to be driven by Alzheimer’s pathology. Each variant tends to strike at a younger age than typical disease, often in the fifties and sixties, when patients are still working and raising families.

A central technical insight of the review is the dissociation between amyloid and tau as explanatory variables. Amyloid biomarkers, whether cerebrospinal fluid assays or amyloid PET, usually confirm that Alzheimer’s biology is present, but amyloid burden correlates poorly with symptom type and severity. Regional tau burden, measured by tau PET or quantified at autopsy, tracks the affected brain network far more closely. In posterior cortical atrophy, tau concentrates in occipital and parietal cortex; in logopenic aphasia, in left temporoparietal language areas; in behavioral variants, in frontal and medial prefrontal regions. Neurodegeneration and metabolic dysfunction, seen on MRI and FDG-PET, mirror this tau topography. In other words, amyloid may set the stage, but tau’s choreography determines which act the audience sees.

This network-based view draws on a foundational observation in neurodegeneration research: degenerative diseases appear to target large-scale brain networks rather than random collections of neurons. Tau pathology seems to propagate along connected circuits, and the selective vulnerability of particular networks, why posterior cortical networks fail while hippocampal ones hold out in a given patient, remains one of the field’s central unsolved questions. Atypical variants, the authors argue, are natural experiments in selective vulnerability. Because the same disease biology produces radically different regional outcomes, these patients offer a uniquely powerful window into which immune-glial, vascular, protein-handling, synaptic, or genetic factors tip particular circuits into early failure.

The evidence for such modifiers is accumulating. Neuropathological studies have shown that clinical variants of Alzheimer’s disease carry distinct regional patterns of neurofibrillary tangle accumulation and distinct neuroinflammatory profiles. Microglial activation, tracked by translocator protein PET, is elevated in posterior cortical atrophy in patterns that differ from amnestic disease, and inflammation appears to co-localize with tau in early-onset cases. Genetic findings add another layer: TREM2 risk variants, which alter microglial function, are associated with atypical presentations, while APOE epsilon4, the strongest common genetic risk factor for typical late-onset disease, shows a more complex relationship with phenotype, influencing tau and amyloid PET patterns and functional connectivity in posterior cortical atrophy and logopenic aphasia. Tau itself is molecularly diverse, with cryo-EM studies revealing distinct filament structures, and tau strain differences have been proposed to contribute to clinical heterogeneity.

Co-pathology further complicates the picture. Many older brains harbor more than one misfolded protein, and comorbid Lewy body pathology, vascular injury, or TDP-43 can reshape both the clinical presentation and the pace of decline. Studies of early-onset versus late-onset disease show differing burdens of comorbid neuropathology, and community-based autopsy studies reveal that many people with substantial Alzheimer’s pathology never developed dementia, highlighting the role of resilience and compensatory factors. Age itself matters: younger patients tend to have purer, more focal pathology, which may partly explain why atypical phenotypes cluster at younger ages of onset.

The review’s core proposal is a four-axis framework designed to capture this heterogeneity without abandoning the biological definition of the disease. The first axis is the clinical phenotype, the observable syndrome such as posterior cortical atrophy or logopenic aphasia. The second is the AD biological context, encompassing the presence of amyloid and tau, co-pathologies, and molecular modifiers such as genetic risk and inflammatory state. The third is network topography, the regional pattern of tau, atrophy, and dysfunction that defines which circuits are under attack. The fourth is tempo, the rate of clinical and biomarker progression, which ranges from indolent to rapidly progressive and is increasingly recognized as a distinct dimension of disease rather than a footnote. Recording all four axes, the authors contend, would allow two patients with identical amyloid status to be described in terms that actually predict their trajectories.

The practical stakes are considerable. Diagnostic delays in atypical Alzheimer’s are notorious, with posterior cortical atrophy patients often waiting years for a correct diagnosis while being treated for cataracts, anxiety, or stress. Biomarker frameworks built around the amyloid-tau-neurodegeneration scheme confirm biological Alzheimer’s disease but say little about phenotype, network, or pace, leaving clinicians and trialists with coarse categories. Clinical trials designed around memory outcomes may miss benefit in patients whose relevant endpoints are visual processing or language fluency, and cohorts mixing typical and atypical cases without stratification can dilute or obscure treatment effects. A recent call to action on improving the clinical trial landscape for atypical variants underscores the point: without network-tailored outcomes and phenotype-specific stratification, trials risk failing for reasons unrelated to the drug’s biology.

The framework also reframes a deeper conceptual question the authors have pressed before: whether Alzheimer’s disease, defined by a shared molecular pathology but expressed through such divergent clinical and anatomical routes, is best understood as one disease or a family of diseases. By separating what is common, the amyloid-tau biology, from what varies, the topography, tempo, and biological context, the multi-axis model offers a way to keep a unified biological diagnosis while acknowledging genuine subtypes within it. For the growing population of patients diagnosed with Alzheimer’s disease in their fifties and sixties with symptoms that bear no resemblance to the textbook memory disorder, that shift in descriptive precision is not academic. It determines whether their disease is recognized early, whether they are enrolled in the right trials, and whether the outcomes measured in those trials reflect the brain networks actually failing beneath their symptoms.

Subject of Research: A multi-axis framework for defining clinical, pathological, network, and progression heterogeneity in atypical Alzheimer disease

Article Title: Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity

Article References: Grinberg, L. T., & Murray, M. E. (2026). Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity. Nature Reviews Neurology. https://doi.org/10.1038/s41582-026-01267-y

Image Credits: AI Generated

DOI: 10.1038/s41582-026-01267-y

Keywords: Alzheimer's disease, atypical Alzheimer disease, posterior cortical atrophy, primary progressive aphasia, tau pathology, amyloid-beta, biomarkers, selective vulnerability, brain networks, neuroinflammation, APOE, clinical trials

The cortical hierarchy is one of the organizing principles of modern neuroscience. At its lower tiers sit primary sensory and motor areas, which handle raw inputs from the eyes, ears, and body. Moving up the hierarchy, regions become progressively less tied to immediate sensation and more engaged in abstraction, prediction, language, and executive control, culminating in association cortices such as the prefrontal and parietal networks. Neuroscientists have mapped this gradient in detail using functional imaging, showing that higher-order regions integrate information from many lower-order sources. What has remained less clear is how the brain’s physical cabling supports this flow, and whether individual differences in that cabling relate to differences in how people think and reason.

White matter provides the anatomical substrate for that communication. Composed largely of axons wrapped in myelin, a fatty sheath that accelerates electrical signaling, white matter tracts form the brain’s long-distance infrastructure. Techniques such as diffusion magnetic resonance imaging allow researchers to infer the orientation and coherence of these fibers in living brains by tracking the movement of water molecules through tissue. Measures derived from these scans, including fractional anisotropy and related diffusion metrics, serve as indirect indicators of tract organization, myelination, and fiber density. In the new work, the researchers applied such methods to map how white matter pathways connect regions across successive levels of the cortical hierarchy.

The central finding is that the tracts most strongly associated with cognitive performance are not confined to any single level of the hierarchy. Instead, they thread through it, linking early sensory areas to intermediate association regions and onward to the most abstract frontal territories. This pattern suggests that efficient long-range communication across hierarchical levels, rather than the strength of any isolated hub, may be a key anatomical ingredient of higher cognition. The result aligns with a growing body of evidence that intelligence and related abilities depend on the coordinated activity of distributed networks, and that the brain’s wiring diagram constrains how effectively those networks can synchronize.

The notion of cognitive diversity is central to the study’s framing. Rather than ranking individuals on a single scale of ability, the researchers emphasize the many dimensions along which human cognition varies: some people excel at verbal reasoning, others at spatial manipulation, working memory, or cognitive control. The analysis indicates that distinct patterns of white matter organization across the cortical hierarchy relate to these different profiles. In other words, the anatomical substrate of cognition is not a single pipeline but a heterogeneous set of pathways whose varying configurations may give rise to the rich variety of mental strengths seen in the population.

Methodologically, the study draws on large-scale neuroimaging datasets in which hundreds to thousands of participants undergo diffusion imaging alongside extensive behavioral testing. This combination allows researchers to correlate tract-level anatomical measures with performance across multiple cognitive domains while controlling for confounds such as age, sex, and overall brain size. Statistical models in such analyses typically account for the fact that neighboring tracts share biological influences, and modern approaches increasingly test whether findings replicate across independent samples. The emphasis on hierarchical positioning, rather than simple regional labels, represents a methodological refinement: instead of asking whether a named tract predicts a named test, the authors asked whether connectivity spanning particular hierarchical distances predicts cognitive outcomes.

The findings carry implications for several long-standing debates. One concerns the neural basis of general intelligence, often indexed by the tendency of performance across diverse cognitive tests to correlate. Network-based accounts propose that a highly connected brain, with efficient communication among distributed regions, supports the flexible integration that demanding tasks require. The new evidence that white matter tracts span the hierarchy in a way that tracks cognitive diversity lends anatomical weight to that proposal, suggesting that the architecture of interregional communication is where some of the variance in human cognitive ability is physically realized.

A second implication concerns development and plasticity. White matter continues to mature well into adulthood, with myelination proceeding in a hierarchical fashion, from primary sensory tracts toward frontal pathways, over years and decades. If hierarchical connectivity supports cognitive diversity, then developmental changes in white matter may help explain why cognitive profiles shift across the lifespan, and why adolescence and early adulthood, periods of ongoing frontal myelination, are marked by gains in abstract reasoning and executive function. The study’s framework also offers a lens on conditions in which white matter integrity is disrupted, where atypical hierarchical connectivity may contribute to differences in cognitive function.

The researchers and outside commentators alike caution against overinterpreting the results. Diffusion imaging provides indirect measures of microstructure, and the relationship between diffusion metrics and the underlying biology of axons and myelin remains an active area of technical debate. Correlational findings in healthy adults cannot establish causation, and cognitive abilities reflect the interplay of genetics, environment, education, and experience alongside brain structure. The authors frame their contribution as a step toward an anatomical account of cognitive variation, one that must be integrated with functional imaging, genetic data, and longitudinal designs before its full significance can be judged.

Even with those caveats, the study adds a compelling piece to the picture of the human brain as a hierarchically organized communication network. By showing that the same white matter infrastructure carries signals from the senses to the heights of abstraction, and that the organization of that infrastructure varies meaningfully from person to person, the work underscores a principle increasingly central to neuroscience: to understand how minds differ, one must look not only at where the brain is active, but at how its regions are wired together across the full span of the cortical hierarchy.

Subject of Research: The role of anatomical white matter tracts spanning the cortical hierarchy in supporting individual differences in cognition

Article Title: Anatomical white matter tracts span the cortical hierarchy to support cognitive diversity

Article References: Bagautdinova, J., Shafiei, G., Luo, A. C., Pecsok, M. K., Salo, T., Alexander-Bloch, A. F., Bassett, D. S., Gardner, M. E., Gur, R. E., Gur, R. C., Mackey, A. P., Meisler, S. L., Misic, B., Moore, T. M., Roalf, D. R., Shinohara, R. T., Sydnor, V. J., Tong, T. T., Yeh, F.-C., … Satterthwaite, T. D. (2026). Anatomical white matter tracts span the cortical hierarchy to support cognitive diversity. Nature Human Behaviour. https://doi.org/10.1038/s41562-026-02559-5

Image Credits: AI Generated

DOI: 10.1038/s41562-026-02559-5

Keywords: white matter, cortical hierarchy, cognitive diversity, diffusion MRI, myelination, brain connectivity, neuroimaging, intelligence, association cortex, cognitive ability, brain networks, human cognition

A team at the Montréal Neurological Institute of McGill University has now published a detailed account of how they have managed this complexity, both inside their own laboratory and for the wider community. Writing in Nature Protocols, Zhen-Qi Liu, Vincent Bazinet and colleagues, led by Bratislav Misic, describe netneurotools, an open-source Python toolkit that has been continuously developed and maintained by the laboratory’s trainees since its inception. The paper is both a practical protocol for carrying out network neuroscience analyses and a manifesto for a different way of building scientific software, one in which the informal, ad hoc scripts that every laboratory accumulates are treated as a legitimate, shareable scientific resource.

The philosophy behind the toolkit is disarmingly simple. The authors describe netneurotools as the Swiss army knife of the laboratory: a collection of functions and routines that the group uses constantly but that belong to no established pipeline or package. Where large neuroimaging platforms excel at well-defined tasks such as preprocessing functional magnetic resonance imaging or reconstructing diffusion data, they are not designed to interoperate with one another. The gaps between them, the authors argue, are precisely where trainees are forced to improvise isolated heuristics and workarounds. netneurotools formalizes those improvisations, turning scattered personal scripts into documented, tested, reusable code that anyone can pick up.

Technically, the toolkit is built on the familiar foundations of the scientific Python ecosystem, drawing on array programming libraries such as NumPy, the algorithms of SciPy, machine learning utilities from scikit-learn, graph structures from NetworkX, and file-reading capabilities from nibabel and nilearn. It extends these foundations with capabilities that are specific to network neuroscience. These include utilities for handling cortical surface meshes and transforming data between the many parcellation schemes that fragment the field, from volumetric atlases to multi-resolution cortical subdivisions. Because a brain map computed on one parcellation cannot be directly compared with a map on another, robust surface-based resampling and interpolation are among the most valuable functions the package provides, sparing researchers from the error-prone manual conversions that have long been a rite of passage in the field.

Network analysis itself forms a second major pillar. The toolkit implements routines for generating group-representative structural brain networks using distance-dependent consensus thresholding, an approach designed to respect the fact that anatomical connection probability falls with physical distance in the brain. It provides algorithms for randomizing weighted networks while preserving key topological properties, a crucial step in any null-model-based analysis, including a simulated annealing method developed by the same group for rigorously controlling network structure. It also implements a library of network communication models, which ask how signals could theoretically travel along the wiring of the brain, from classical shortest-path routing inspired by the Floyd, Roy and Warshall algorithms to navigation strategies and diffusion-style models that better capture the biology of neural signaling.

Statistical machinery rounds out the package. Network neuroscience increasingly relies on spatial statistics, because brain measures are arranged in space and neighboring regions are not independent. netneurotools includes implementations of spatial autocorrelation measures such as Moran’s I and Geary’s C, along with bivariate extensions that quantify spatial associations between two brain maps. It offers null models that preserve the spatial autocorrelation of data before statistical testing, a safeguard against the inflated significance that naive permutation schemes can produce. Dominance analysis, a technique from psychology for assessing the relative importance of correlated predictors in regression, is also available, addressing a common challenge when multiple brain properties compete to explain a neural phenomenon.

The protocol paper walks readers through complete workflows that chain these functions together to answer neurobiologically meaningful questions. Example analyses include relating brain network organization to microarchitectural features such as receptor distributions and cell-type composition, examining how strongly the brain’s structural wiring constrains its functional dynamics across different imaging modalities, and generating spatially informed null models for testing whether an observed pattern of structure-function coupling is unusual. Workflow diagrams in the paper show how data flow from raw parcellated imaging outputs, through the toolkit’s conversion, modeling and statistical layers, to interpretable figures, giving trainees a template they can adapt to their own projects rather than a black box they must trust blindly.

Beyond its technical content, the article makes a cultural argument that is likely to resonate far beyond one laboratory. The authors position netneurotools as a necessary counterweight to out-of-the-box software packages, arguing that smaller, ad hoc functions deserve recognition as real scientific contributions. By opening a window into the inner workings of a laboratory, the toolkit invites a new kind of discourse among research groups, one in which the unglamorous glue code that actually holds a project together is shared, critiqued and improved collectively. The package has been open to contributions from neuroscientists across the globe since its inception, and its development by trainees reflects a deliberate pedagogical choice: writing and maintaining shared infrastructure is itself a form of scientific training.

The timing of this publication is significant. A recent assessment of open-source neuroscience software described the field’s dependence on volunteer-maintained tools as precarious, and the proliferation of analysis pipelines has made reproducibility a persistent concern. By documenting their toolkit in a peer-reviewed protocols journal, the Misic laboratory is making a case that sustainability in computational neuroscience depends not only on large, polished platforms but also on transparent, community-maintained collections of mid-sized tools that bridge the gaps between them. The approach aligns with the FAIR principles for research software, which call for software to be findable, accessible, interoperable and reusable.

For a field whose data keep multiplying in modality and scale, the message is practical and quietly radical at once. The connectome may be the most complicated object ever mapped, but the daily work of studying it is made of thousands of small, concrete operations: converting a file, resampling a surface, rewiring a network, testing a spatial statistic. netneurotools gathers those operations into one open, living toolbox, and in doing so suggests that the health of network neuroscience may depend as much on how generously its practitioners share their everyday tools as on any single breakthrough analysis.

Subject of Research: An open-source, trainee-developed Python toolkit for network neuroscience analysis and brain imaging data integration

Article Title: netneurotools: a trainee-oriented approach to network neuroscience

Article References: Liu, Z.-Q., Bazinet, V., Hansen, J. Y., Milisav, F., Luppi, A. I., Ceballos, E. G., Farahani, A., Suarez, L. E., Shafiei, G., Markello, R. D., & Misic, B. (2026). netneurotools: a trainee-oriented approach to network neuroscience. Nature Protocols. https://doi.org/10.1038/s41596-026-01446-7

Image Credits: AI Generated

DOI: 10.1038/s41596-026-01446-7

Keywords: netneurotools, network neuroscience, Python toolkit, brain imaging, connectomics, open-source software, brain networks, spatial statistics, null models, FAIR principles, McGill University, Nature Protocols

Magnetoencephalography, or MEG, measures the tiny magnetic fields generated by electrical currents flowing through neurons. Unlike functional MRI, which tracks blood flow changes on a timescale of seconds, MEG captures brain activity millisecond by millisecond, making it uniquely suited to studying neural oscillations, the rhythmic fluctuations of electrical activity that occur at frequencies ranging from slow delta and theta waves to faster alpha, beta and gamma rhythms. These rhythms are thought to coordinate communication across distant brain regions, and the degree to which oscillations in separate areas are synchronized, known as functional connectivity, provides a window into how brain networks interact in real time.

In the new research, the authors analyzed MEG recordings to derive measures of oscillation-based functional connectivity across the cortex, asking whether the resulting patterns could sort people with depression into meaningful groups. Rather than assuming that all patients share a single brain profile, the study applied data-driven analytical approaches to the connectivity matrices, searching for reproducible subtypes. The results revealed distinct neurophysiological phenotypes, each defined by a characteristic arrangement of oscillatory coupling across frequency bands and brain regions, that could not be reduced to a single average picture of the depressed brain.

Crucially, the subtypes were not merely statistical curiosities. The study connected them to clinically relevant information, showing that the neurophysiological groups related to differences in symptom profiles and illness characteristics among patients. This matters because depression is famously heterogeneous: two people with the same diagnosis can experience entirely different constellations of low mood, anhedonia, anxiety, sleep disruption, cognitive slowing and suicidal thinking, and they often respond differently to the same treatments. A biological classification that tracks this heterogeneity could eventually help clinicians predict which interventions are most likely to help a given patient, replacing the current trial-and-error approach to treatment selection.

The technical strength of the approach lies in its attention to oscillation frequency. Much of the earlier literature on resting-state brain connectivity has relied on slow hemodynamic signals, which lump together neural processes that unfold at very different speeds. By contrast, the MEG framework used in this work separates connectivity in canonical frequency bands, allowing the researchers to capture, for example, theta-band synchrony between frontal and temporal regions independently of alpha-band coupling between parietal hubs. Because different oscillatory channels are thought to support different cognitive and affective functions, this frequency-resolved view offers a richer and potentially more diagnostically informative description of brain organization than band-averaged measures.

Methodologically, the study had to contend with well-known challenges in MEG research. Magnetic signals from the brain are extraordinarily faint, on the order of femtoteslas, hundreds of millions of times weaker than the Earth’s magnetic field, so recordings are made in shielded rooms with sensitive superconducting sensors. Source estimation, the process of inferring where in the brain a signal originates, is an inverse problem with no unique solution, and the researchers applied established reconstruction pipelines to project sensor-level data onto cortical surface space before computing connectivity. They also had to correct for spatial leakage, a technical artifact in which activity from one brain region bleeds into neighboring estimates and inflates apparent connectivity, a pitfall that has historically undermined some connectivity studies.

Once these technical hurdles were addressed, the analysis compared patients with depression to healthy comparison participants and then examined the internal structure of the patient group. The data-driven clustering of connectivity features yielded subtypes whose differences survived rigorous statistical scrutiny, and the study evaluated whether the identified phenotypes held up under analytical controls. The convergence of evidence across frequency bands and analytical choices strengthened the conclusion that the subtypes reflect genuine structure in the neural data rather than noise, artifacts or idiosyncrasies of a particular processing pipeline.

The clinical implications extend beyond diagnosis. Biomarkers derived from functional connectivity could serve as intermediate endpoints in treatment studies, allowing researchers to measure whether a therapy shifts a patient’s brain toward a healthier connectivity profile long before behavioral symptoms change. They could also illuminate why standard treatments fail for a substantial fraction of patients: if mechanistically distinct forms of depression exist, a treatment targeting one neurophysiological pathway may be ineffective in patients whose illness runs through another. Stratifying patients by oscillatory phenotype in clinical trials could thus sharpen the search for personalized interventions, from medication and psychotherapy to neuromodulation approaches such as transcranial magnetic stimulation, which directly targets oscillatory dynamics in cortical circuits.

Several caveats temper the enthusiasm. MEG is an expensive and technically demanding technology, available mainly in specialized research and clinical centers, so translating oscillation-based phenotyping into routine care would require demonstrating robustness across sites, scanners and patient populations. Depression also co-occurs frequently with anxiety disorders, bipolar illness and other conditions, and future work will need to test whether the connectivity-based subtypes are specific to depression or overlap with other diagnostic categories. Longitudinal studies will be essential to determine whether a patient’s phenotype is stable over time, whether it shifts with treatment, and whether it predicts long-term outcomes such as relapse.

Even with those limitations, the study represents a meaningful step in the broader movement toward biologically informed psychiatry, an effort exemplified by research frameworks that encourage scientists to study dimensions of brain function rather than symptom-based categories alone. By showing that millisecond-scale rhythms of neural activity, captured entirely non-invasively, can carve the depressed population into clinically meaningful groups, the researchers have added a powerful tool to the growing arsenal of computational psychiatry. If subsequent studies replicate and extend these findings, the humble brainwave, long a staple of sleep laboratories and epilepsy clinics, could become a practical instrument for untangling one of medicine’s most heterogeneous and burdensome disorders, bringing the field closer to truly individualized mental health care.

Subject of Research: Magnetoencephalography-based functional connectivity analysis of neural oscillations to identify clinically relevant depression subtypes

Article Title: Magnetoencephalography oscillation-based functional connectivity identifies clinically relevant depression phenotypes

Article References: Liu, W., Vesterinen, M., Andersson, A., Partanen, P., Knapič, S., Juvonen, J. J., Siebenhühner, F., Salonen, A., Renvall, H., Ilmoniemi, R. J., Castrén, E., Isometsä, E., Van De Ville, D., Palva, J. M., & Palva, S. (2026). Magnetoencephalography oscillation-based functional connectivity identifies clinically relevant depression phenotypes. Nature Mental Health. https://doi.org/10.1038/s44220-026-00723-4

Image Credits: AI Generated

DOI: 10.1038/s44220-026-00723-4

Keywords: magnetoencephalography, depression, functional connectivity, neural oscillations, biomarkers, psychiatry, precision medicine, neuroimaging, brain networks, clinical phenotypes, mental health, computational psychiatry

To appreciate why this matters, one must first understand the stubborn technical difficulties that have long constrained rodent fMRI. Mapping brain-wide networks in behaving animals remains a formidable challenge for reasons rooted in the basic mechanics of magnetic resonance. Conventional fMRI relies on echo-planar imaging sequences that generate loud acoustic noise, often exceeding one hundred decibels inside the scanner bore. For a human volunteer lying still with ear protection, that noise is an annoyance. For a mouse, an animal whose hearing is far more sensitive and whose experimental value depends on natural behavior, the acoustic barrage is a confound of the first order. It activates auditory circuits, triggers stress responses, alters arousal, and contaminates precisely those network signals researchers hope to measure.

The problem compounds when the goal is to image animals that are awake and moving. Standard echo-planar sequences are exquisitely sensitive to motion, and even the small head movements of a behaving mouse produce artifacts that can dwarf the subtle blood-oxygenation-level-dependent signals of interest. Traditional workarounds, such as anesthetizing animals or restraining their heads while training them to tolerate the scanner, solve one problem by creating another. Anesthesia suppresses consciousness and reorganizes neural dynamics, so the networks measured under it are not the networks of a behaving animal. Head fixation permits imaging during limited tasks but rules out the rich, ethologically meaningful behaviors, navigation, social interaction, foraging, that make rodents so valuable as models in the first place.

SORDINO-fMRI addresses both obstacles at once. The framework is silent, eliminating the acoustic confound that plagues conventional sequences, and it is motion-resistant by design, so that the global dynamics of freely orchestrating animals can be captured without the ghosting, blurring, and signal dropout that normally accompany movement in the magnet. According to the News & Views summary, the method captures global dynamics during complex behaviors in mice while enabling artifact-free simultaneous network-level recordings with cellular or chemical validation. That last clause deserves emphasis: SORDINO-fMRI does not operate in isolation but can be paired, in the same scanning session, with techniques that read out neural activity or neurochemistry at the cellular scale. This creates a rare multimodal platform in which whole-brain network dynamics and mechanistic ground truth can be acquired in parallel.

The significance of this convergence becomes clear when one considers how neuroscience has been pulled in two directions by its tools. On one side, techniques such as widefield calcium imaging, two-photon microscopy, and high-density electrophysiology offer cellular or near-cellular resolution, but each covers only a limited field of view. Landmark large-scale efforts, including work from the International Brain Laboratory and the population recordings of Stringer and colleagues as well as Steinmetz, Zatka-Haas, Carandini, and Harris, have shown how much can be learned from recording many neurons or many brain regions simultaneously. Yet even hundreds of targeted probes cannot deliver a truly brain-wide picture in a small rodent brain without gaps. On the other side, fMRI delivers that brain-wide coverage but has historically lacked cellular specificity and, in rodents, behavioral realism. SORDINO-fMRI aims to close this gap, bringing whole-brain functional imaging into the awake, behaving regime where modern systems neuroscience now lives.

The timing of this advance is not accidental. The past several years have seen an intensifying effort to legitimize and improve rodent fMRI as a translational bridge between human imaging and circuit neuroscience. Reviews and methodological papers by Gao and colleagues, by Mandino, Vujic, Grandjean, and Lake, and by Daley, Pan, Kaundinya, and Keilholz have catalogued both the promise and the pitfalls of preclinical fMRI, from anesthesia confounds to the challenge of interpreting blood-oxygenation signals in a brain the size of a hazelnut. Studies by Yu and colleagues, and by Bolt and colleagues, have pushed toward whole-brain imaging of neural dynamics, while Rauscher and colleagues and Pagani and colleagues have recently expanded the frontier of what functional imaging in rodents can reveal. Lake and colleagues established foundations for imaging neural activity in awake animals that have informed the field’s trajectory. Shemesh’s commentary situates SORDINO-fMRI squarely within this arc, arguing that it opens new opportunities in preclinical imaging and systems neuroscience.

What might those opportunities look like in practice? Consider a mouse navigating a virtual or physical maze while its brain is imaged silently. Because the animal is awake and behaving, the researchers can ask how distributed networks, hippocampal, cortical, subcortical, coordinate in real time as the animal makes decisions, encodes space, or responds to rewards. Because the readout is artifact-free, fluctuations in the blood-oxygenation signal can be attributed to neural dynamics rather than to head motion or acoustic startle. And because simultaneous cellular or chemical validation is possible, the researchers can anchor the macroscopic network measurements to known quantities: the firing of specific neuronal populations, or the release of specific neuromodulators. This triangulation across scales is precisely what the field has needed to translate insights about circuit mechanisms into models that can be tested against human brain imaging, and vice versa.

The preclinical implications extend into translational medicine. Rodent models are indispensable for studying neurological and psychiatric disease, from Parkinson’s and epilepsy to depression and schizophrenia, but the field has long struggled with the failure of therapies that succeed in mice and fail in humans. A significant part of that failure is measurement: preclinical readouts often do not correspond to the outcome measures used in clinical trials. A method that can image brain-wide network function in behaving disease-model mice, with the same modality, fMRI, that is used in patients, offers a more direct translational axis. Network-level phenotypes measured with SORDINO-fMRI could, in principle, be compared quantitatively with resting-state and task-based networks in human patients, enabling a more rigorous back-and-forth between bench and bedside.

None of this diminishes the substantial work that remains. Interpreting fMRI signals in rodents requires careful attention to neurovascular coupling, which may differ across species, brain regions, and behavioral states. Combining fMRI with optogenetics, electrophysiology, or pharmacology in the same session demands exquisite engineering, from radiofrequency-compatible hardware to protocols that keep animals healthy and cooperative inside a magnet. Shemesh, who directs research at the Weizmann Institute of Science and the Champalimaud Foundation and who has long championed advanced diffusion and functional MRI methods, is well placed to evaluate these challenges, and his commentary treats SORDINO-fMRI as a genuine advance rather than a finished solution. He discloses service on the scientific advisory board of Bruker Biospin, a reminder that the industrial ecosystem around preclinical imaging is actively engaged with these developments.

Still, the phrase that will linger with readers is the one Shemesh chose for his title: a silent leap. The word silent is literal, a reference to the acoustically quiet acquisition that makes natural behavior possible inside the scanner. But it also captures the way this methodological shift arrives without fanfare amid the louder headlines of AI models and brain-computer interfaces, quietly removing constraints that have shaped decades of experimental design. If SORDINO-fMRI performs as described, the neuroscience community gains something it has never had before: a way to watch entire mammalian brains orchestrate real behavior, at network scale, validated at the cellular level, all in a single experiment. For preclinical imaging and systems neuroscience alike, that is not an incremental improvement. It is a change in what questions can be asked at all, and the answers to those questions may reshape how we understand the brain in motion, in health, and in disease.

One useful way to situate the advance is through the physics of the blood-oxygenation-level-dependent signal itself. Because the hemodynamic response that fMRI measures unfolds over roughly a second or more, it is inherently slower than the millisecond-timescale spiking that electrophysiology captures, and its amplitude depends on local neurovascular mechanisms rather than on neural activity alone. This is why pairing network-level imaging with cellular or chemical readouts in the same session is so valuable: it allows investigators to calibrate what the vascular signal actually reflects under a given behavioral state, rather than assuming that coupling parameters measured in anesthetized preparations carry over unchanged.

The multimodal design also speaks to a broader trend in systems neuroscience toward convergent evidence. When a macroscopic network fluctuation can be checked against, for example, the concurrent firing of a defined neuronal population or the release of a neuromodulator, interpretations move from plausible to testable. Such cross-scale validation has historically required separate experiments in separate animals, introducing variability that complicates comparison. Acquiring the modalities simultaneously in the same animal ties them together temporally, so that a transient change in global dynamics can be linked to its cellular substrate at the very moment it occurs. For preclinical studies of disease models, where network alterations may be subtle and state-dependent, that temporal alignment could prove as consequential as the silence and motion resistance themselves.

Subject of Research: A silent, motion-resistant fMRI framework for brain-wide imaging of behaving mice

Article Title: A silent leap in neuroimaging

Article References: Shemesh, N. (2026). A silent leap in neuroimaging. Nature Neuroscience. https://doi.org/10.1038/s41593-026-02401-1

Image Credits: AI Generated

DOI: 10.1038/s41593-026-02401-1

Keywords: SORDINO-fMRI, functional MRI, neuroimaging, rodent brain imaging, awake behaving mice, brain networks, systems neuroscience, preclinical imaging, Nature Neuroscience, Noam Shemesh, MacKinnon, silent fMRI